Skip to content

Risk factors for nasogastric tube syndrome in patients with dysphagia: a case-control study

Risk factors for nasogastric tube syndrome in patients with dysphagia: a case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125230
Enrollment
Unknown
Registered
2026-05-22
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia

Interventions

Case group:None
Control group:None

Sponsors

The People’s Hospital of Longgang District, Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Case group: 1. Age >= 18 years; 2. Laryngoscopy confirming leakage/aspiration (PAS >= grade 3); 3. Nasogastric tube in place for >= 24 hours; 4. Laryngoscopic assessment meeting all three criteria of ‘restricted vocal cord movement, epiglottic mucosal oedema, and abnormal epiglottic shape’ as described in the literature; 5. Complete clinical data; 6. Clinical diagnosis of stroke. Control group: 1. Age >= 18 years; 2. Laryngoscopy confirming leakage/aspiration (PAS >= grade 3); 3. Nasogastric tube in place for >=24 hours; 4. No evidence of nasogastric tube syndrome at laryngoscopic assessment; 5. Complete clinical data; 6. Clinical diagnosis of stroke. 7. Matched with the case group in a 1:2 ratio for age, sex and primary diagnosis (to reduce confounding bias);

Exclusion criteria

Exclusion criteria: 1. Patients with pre-existing vocal cord paralysis or severe laryngeal pathology; 2. Patients with a history of neck surgery or radiotherapy, or those with head and neck tumours; 3. Patients with severe cognitive impairment who are unable to cooperate during laryngoscopy; 4. Patients whose clinical records are missing key information (e.g. laryngoscopy reports or imaging); 5. Patients whose nasogastric tube was removed within 48 hours of intubation.

Design outcomes

Primary

MeasureTime frame
Nasogastric Tube Syndrome ;

Secondary

MeasureTime frame
Duration of nasogastric tube;Repeated nasogastric tube insertion;History of diabetes;hypertension;brain lesion;Course of disease;consciousness;Tracheotomy ;Budesonide nebulisation;History of gastroesophageal;Nutritional score;sedative-hypnotic drugs;

Countries

China

Contacts

Public ContactHongmei Guan

The People’s Hospital of Longgang District, Shenzhen

gguan21@139.com+86 150 9991 8204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026